GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (LSE:NCYT) » Definitions » Additional Paid-In Capital

Novacyt (LSE:NCYT) Additional Paid-In Capital : £50.67 Mil(As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Novacyt Additional Paid-In Capital?


Novacyt's quarterly additional paid-in capital stayed the same from Dec. 2022 (£50.67 Mil) to Jun. 2023 (£50.67 Mil) and stayed the same from Jun. 2023 (£50.67 Mil) to Dec. 2023 (£50.67 Mil).

Novacyt's annual additional paid-in capital stayed the same from Dec. 2021 (£50.67 Mil) to Dec. 2022 (£50.67 Mil) and stayed the same from Dec. 2022 (£50.67 Mil) to Dec. 2023 (£50.67 Mil).

Novacyt Additional Paid-In Capital Historical Data

The historical data trend for Novacyt's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novacyt Additional Paid-In Capital Chart

Novacyt Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.00 50.67 50.67 50.67 50.67

Novacyt Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.67 50.67 50.67 50.67 50.67

Novacyt Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Novacyt Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Novacyt's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Novacyt (LSE:NCYT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (LSE:NCYT) » Definitions » Additional Paid-In Capital
Comparable Companies
XPAR:AFME XPAR:ALMKT XPAR:ALTHE XPAR:ALTER XPAR:ALBLU XPAR:ALDMS XPAR:ALEMG XPAR:ALIKO XPAR:ALSGD XPAR:ALIMP ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
NVYTF:USA ALNOV:France NYZ:Germany
Address
13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140
Website
https://www.novacyt.com
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt (LSE:NCYT) Headlines

No Headlines